These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 24009293)
21. Cost analysis for renal dialysis: Case study from Indochina. Joob B; Wiwanitkit V Saudi J Kidney Dis Transpl; 2017; 28(4):948. PubMed ID: 28748907 [No Abstract] [Full Text] [Related]
23. Economic evaluation in cardiology. Maniadakis N; Vardas P; Mantovani LG; Fattore G; Boriani G Europace; 2011 May; 13 Suppl 2():ii3-8. PubMed ID: 21518746 [TBL] [Abstract][Full Text] [Related]
24. Identifying target audiences: who are the guidelines for? : article 1 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Yawn BP; Akl EA; Qaseem A; Black P; Campos-Outcalt D; Proc Am Thorac Soc; 2012 Dec; 9(5):219-24. PubMed ID: 23256162 [TBL] [Abstract][Full Text] [Related]
25. Strategies for incorporating resource allocation and economic considerations: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Matchar DB; Mark DB Chest; 2008 Jun; 133(6 Suppl):132S-140S. PubMed ID: 18574263 [TBL] [Abstract][Full Text] [Related]
26. Guideline use: a survey of dietitians working with adult kidney transplant recipients. Orazio LK; Murray EM; Campbell KL Nephrology (Carlton); 2012 Jul; 17(5):508-13. PubMed ID: 22369343 [TBL] [Abstract][Full Text] [Related]
27. Consensus-based cross-European recommendations for the identification, measurement and valuation of costs in health economic evaluations: a European Delphi study. van Lier LI; Bosmans JE; van Hout HPJ; Mokkink LB; van den Hout WB; de Wit GA; Dirksen CD; Nies HLGR; Hertogh CMPM; van der Roest HG Eur J Health Econ; 2018 Sep; 19(7):993-1008. PubMed ID: 29260341 [TBL] [Abstract][Full Text] [Related]
28. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. Goldsmith DJ; Covic A; Fouque D; Locatelli F; Olgaard K; Rodriguez M; Spasovski G; Urena P; Zoccali C; London GM; Vanholder R Nephrol Dial Transplant; 2010 Dec; 25(12):3823-31. PubMed ID: 20829401 [TBL] [Abstract][Full Text] [Related]
29. Adaptation, evaluation, and updating of guidelines: article 14 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Burgers JS; Anzueto A; Black PN; Cruz AA; Fervers B; Graham ID; Metersky M; Woodhead M; Yawn BP; Proc Am Thorac Soc; 2012 Dec; 9(5):304-10. PubMed ID: 23256175 [TBL] [Abstract][Full Text] [Related]
30. Implementation of a guideline for low back pain management in primary care: a cost-effectiveness analysis. Becker A; Held H; Redaelli M; Chenot JF; Leonhardt C; Keller S; Baum E; Pfingsten M; Hildebrandt J; Basler HD; Kochen MM; Donner-Banzhoff N; Strauch K Spine (Phila Pa 1976); 2012 Apr; 37(8):701-10. PubMed ID: 21738095 [TBL] [Abstract][Full Text] [Related]
31. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E; Value Health; 2013; 16(2):231-50. PubMed ID: 23538175 [TBL] [Abstract][Full Text] [Related]
32. A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Verbeke F; Lindley E; Van Bortel L; Vanholder R; London G; Cochat P; Wiecek A; Fouque D; Van Biesen W Nephrol Dial Transplant; 2014 Mar; 29(3):490-6. PubMed ID: 24071661 [TBL] [Abstract][Full Text] [Related]
33. Importance of Economic Evaluation in Health Care: An Indian Perspective. Dang A; Likhar N; Alok U Value Health Reg Issues; 2016 May; 9():78-83. PubMed ID: 27881265 [TBL] [Abstract][Full Text] [Related]
34. Health economics of care for patients with cancer and intractable disease in Japan. Hisashige A; Katayama T; Mikasa H Support Care Cancer; 1998 Nov; 6(6):503-10. PubMed ID: 9833298 [TBL] [Abstract][Full Text] [Related]
35. Health economics in HIV disease. A review of the European literature. Youle M; Trueman P; Simpson K Pharmacoeconomics; 1999; 15 Suppl 1():1-12. PubMed ID: 10537438 [TBL] [Abstract][Full Text] [Related]
36. Disease management in CKD: panacea or futility? Ronco C Int J Artif Organs; 2006 Feb; 29(2):153. PubMed ID: 16552662 [No Abstract] [Full Text] [Related]
37. Improving the use of research evidence in guideline development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications. Edejer TT Health Res Policy Syst; 2006 Dec; 4():23. PubMed ID: 17147813 [TBL] [Abstract][Full Text] [Related]
38. The limited incorporation of economic analyses in clinical practice guidelines. Wallace JF; Weingarten SR; Chiou CF; Henning JM; Hohlbauch AA; Richards MS; Herzog NS; Lewensztain LS; Ofman JJ J Gen Intern Med; 2002 Mar; 17(3):210-20. PubMed ID: 11929508 [TBL] [Abstract][Full Text] [Related]
39. The European Renal Best Practice Advisory Board's dialysis initiation guidelines: one size won't fit all. Rosansky SJ Kidney Int; 2011 Nov; 80(10):1005-7. PubMed ID: 22042024 [No Abstract] [Full Text] [Related]
40. Review article: Use of renal registry data for research, health-care planning and quality improvement: what can we learn from registry data in the Asia-Pacific region? Lim TO; Goh A; Lim YN; Morad Z Nephrology (Carlton); 2008 Dec; 13(8):745-52. PubMed ID: 19154324 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]